Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)
Clinical trial NCT03875859 · TERMINATED
Trial details
- NCT number
- NCT03875859
- Sponsor
- Kavita Sarin
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-12
- Primary completion
- 2020-05-14
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.